Editorial Comment to Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration

Koji Mitsuzuka

doi:10.1111/iju.13379

Editorial Comment to Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration

Obstetrics, Gynecology and Urology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	448
Number of pages	1
Journal	International Journal of Urology
Volume	24
Issue number	6
DOIs	https://doi.org/10.1111/iju.13379
Publication status	Published - 2017 Jun

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/iju.13379

Cite this

@article{d12bf92cdb43441195839e5837077491,

title = "Editorial Comment to Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-na{\"i}ve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration",

author = "Koji Mitsuzuka",

year = "2017",

month = jun,

doi = "10.1111/iju.13379",

language = "English",

volume = "24",

pages = "448",

journal = "International Journal of Urology",

issn = "0919-8172",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - JOUR

T1 - Editorial Comment to Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer

T2 - The Kyoto-Baltimore collaboration

AU - Mitsuzuka, Koji

PY - 2017/6

Y1 - 2017/6

UR - http://www.scopus.com/inward/record.url?scp=85020166366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020166366&partnerID=8YFLogxK

U2 - 10.1111/iju.13379

DO - 10.1111/iju.13379

M3 - Comment/debate

C2 - 28544352

AN - SCOPUS:85020166366

VL - 24

SP - 448

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 6

ER -

Editorial Comment to Exploring the optimal sequence of abiraterone and enzalutamide in patients with chemotherapy-naïve castration-resistant prostate cancer: The Kyoto-Baltimore collaboration

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this